HeartSciences (HSCS) Current Leases (2022 - 2026)
HeartSciences (HSCS) posted quarterly Current Leases of $139026.0 for Q2 2026, up 16.32% year-on-year from $119518.0 in Q2 2025, and up 16.32% on a QoQ basis from $119518.0 in Q4 2025.
HeartSciences (HSCS) Current Leases (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Current Leases for 5 consecutive years, with $139026.0 the latest figure, recorded in Q2 2026.
- Quarterly Current Leases rose 16.32% year-over-year to $139026.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $139026.0 (up 16.32% YoY) and the FY2026 annual result came in at $139026.0, up 16.32% from the prior year.
- Current Leases grew to $139026.0 in Q2 2026 per HSCS's latest filing, from $119518.0 in the prior quarter.
- Over the last five years, Current Leases for HSCS reached as high as $139026.0 in Q2 2026 and fell as low as $29535.0 in Q2 2023.
- A 5-year average of $96406.3 and a median of $104347.5 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases sank 67.53% — and 2024, when it soared 246.35%.
- Year by year, Current Leases stood at $31232.0 in 2022, then jumped by 202.46% to $94463.0 in 2023, then rose by 17.13% to $110645.0 in 2024, then gained by 8.02% to $119518.0 in 2025, then gained by 16.32% to $139026.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $139026.0, $119518.0, and $128977.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 20.50 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | - |
| 10 | HeartSciences | 6.64 Mn | 4.94 Mn | - | 139,026.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 139,026.00 |
| Dec 31, 2025 | 119,518.00 |
| Oct 31, 2025 | 128,977.00 |
| Jul 31, 2025 | 124,173.00 |
| Apr 30, 2025 | 119,518.00 |
| Jan 31, 2025 | 115,015.00 |
| Oct 31, 2024 | 110,645.00 |
| Jul 31, 2024 | 106,402.00 |
| Apr 30, 2024 | 102,293.00 |
| Jan 31, 2024 | 98,319.00 |
| Oct 31, 2023 | 94,463.00 |
| Jul 31, 2023 | 70,871.00 |
| Apr 30, 2023 | 29,535.00 |
| Oct 31, 2022 | 31,232.00 |
| Jul 31, 2022 | 61,546.00 |
| Apr 30, 2022 | 90,968.00 |